Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

REPLIGEN CORP Director's Dealing 2009

May 20, 2009

30826_dirs_2009-05-20_1596e776-713c-4310-8f6b-e0813975f5af.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2009-05-15

Reporting Person: BVF PARTNERS L P/IL (10% Owner, Group Member)
Reporting Person: BIOTECHNOLOGY VALUE FUND L P (10% Owner, Group Member)
Reporting Person: BIOTECHNOLOGY VALUE FUND II LP (10% Owner, Group Member)
Reporting Person: BVF INVESTMENTS LLC (10% Owner, Group Member)
Reporting Person: BVF INC/IL (10% Owner, Group Member)
Reporting Person: LAMPERT MARK N (10% Owner, Group Member)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 825750 Direct
Common Stock 534400 Direct
Common Stock 1856700 Direct
Common Stock 3216850 Indirect
Common Stock 3216850 Indirect
Common Stock 3216850 Indirect

Footnotes

F1: The shares of Common Stock are directly beneficially owned by Biotechnology Value Fund, L.P. ("BVF"), a Delaware limited
partnership.

F2: The shares of Common Stock are directly beneficially owned by Biotechnology Value Fund II, L.P. ("BVF2"), a Delaware limited
partnership.

F3: The shares of Common Stock are directly beneficially owned by BVF Investments, LLC ("BVFLLC"), a Delaware limited liability
company. Pursuant to the operating agreement of BVFLLC, BVF Partners, L.P., a Delaware limited partnership ("Partners") is
authorized, among other things, to invest the contributed capital of Samana Capital, L.P., the majority member of BVFLLC, in
the shares of Common Stock and other securities and to vote, exercise or convert and dispose of such securities and is
entitled to receive fees based on assets under management and, subject to certain exceptions, allocations based on realized
and unrealized gains on such assets.

F4: The shares of Common Stock are indirectly beneficially owned by Partners. Partners is the general partner of BVF and BVF2
and is the manager of BVFLLC.

F5: The shares of Common Stock are indirectly beneficially owned by BVF Inc., a Delaware corporation ("BVF Inc."). BVF Inc. is
the general partner of Partners.

F6: Mark N. Lampert is the sole shareholder, sole director, and an officer of BVF Inc.